Show simple item record

Benign tumors in myotonic dystrophy type I target disease-related cancer sites

dc.contributor.authorAlsaggaf, Rotana
dc.contributor.authorSt. George, Diane Marie M.
dc.contributor.authorZhan, Min
dc.contributor.authorPfeiffer, Ruth M.
dc.contributor.authorWang, Youjin
dc.contributor.authorAnderson, Lesley A.
dc.contributor.authorLiu, Zhiwei
dc.contributor.authorKoshiol, Jill
dc.contributor.authorBauer, Andrew J.
dc.contributor.authorWagner, Kathryn R.
dc.contributor.authorGreene, Mark H.
dc.contributor.authorAmr, Sania
dc.contributor.authorGadalla, Shahinaz M.
dc.date.accessioned2020-06-28T19:20:01Z
dc.date.available2020-06-28T19:20:01Z
dc.date.issued2019-08
dc.identifier.citationAlsaggaf , R , St. George , D M M , Zhan , M , Pfeiffer , R M , Wang , Y , Anderson , L A , Liu , Z , Koshiol , J , Bauer , A J , Wagner , K R , Greene , M H , Amr , S & Gadalla , S M 2019 , ' Benign tumors in myotonic dystrophy type I target disease-related cancer sites ' , Annals of Clinical and Translational Neurology , vol. 6 , no. 8 , pp. 1510-1518 . https://doi.org/10.1002/acn3.50856en
dc.identifier.issn2328-9503
dc.identifier.otherPURE: 159615733
dc.identifier.otherPURE UUID: 9b30a243-fdfe-4fce-9bb4-8697422c47c0
dc.identifier.otherScopus: 85070449646
dc.identifier.otherPubMed: 31402615
dc.identifier.otherORCID: /0000-0002-1000-3649/work/75446028
dc.identifier.urihttps://hdl.handle.net/2164/14586
dc.descriptionAcknowledgments The authors thank Ms. Emily Carver, BS, and Mr. David Ruggieri, BS, both from the Information Management Services Inc. (Calverton, MD, USA) for their important contributions to database management. This study is based on data from the CPRD GOLD database October 2016 release, obtained from the UK Medicines and Healthcare Products Regulatory Agency, Hospital Episode Statistics (HES) database (Copyright © (2016)), and Office of National Statistics (ONS) database (Copyright ©(2016)) reused with the permission of The Health &Social Care Information Centre. All rights reserved. The interpretation and conclusions contained in this study are those of the authors aloneen
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofAnnals of Clinical and Translational Neurologyen
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicine (General)en
dc.subjectNeuroscience(all)en
dc.subjectClinical Neurologyen
dc.subject.lccR1en
dc.titleBenign tumors in myotonic dystrophy type I target disease-related cancer sitesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/acn3.50856
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85070449646&partnerID=8YFLogxKen
dc.identifier.vol6en
dc.identifier.iss8en


Files in this item

Thumbnail
Name:
Alsagaff_etal_ACTN_Benign_Tumo ...
Size:
318.0Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record